XML 31 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Convertible Preferred Stock and Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2025
Convertible Preferred Stock And Stockholders Equity Disclosure [Abstract]  
Summary of stock option activity and related information under all equity plans

The following table summarizes stock option activity and related information under all equity plans for the period ended September 30, 2025:

 

 

 

Number of
Options

 

 

Weighted-
Average Price

 

Balance at December 31, 2024

 

 

10,722,674

 

 

$

10.99

 

Granted

 

 

3,690,400

 

 

 

1.29

 

Exercised

 

 

(832

)

 

 

1.32

 

Cancelled

 

 

(1,814,843

)

 

 

7.45

 

Balance at September 30, 2025

 

 

12,597,399

 

 

$

8.66

 

Summary of restricted stock unit activity under the Plan

Restricted stock unit activity under all equity and stock option plans is summarized as follows:

 

 

 

Number of
Restricted Stock Units

 

 

Weighted-
Average Grant Date Fair Value per Share

 

Balance at December 31, 2024

 

 

6,214,064

 

 

$

15.50

 

Granted

 

 

3,395,020

 

 

 

1.20

 

Vested

 

 

(1,407,586

)

 

 

15.79

 

Cancelled

 

 

(1,554,405

)

 

 

7.59

 

Balance at September 30, 2025

 

 

6,647,093

 

 

$

9.98

 

Schedule of allocation of stock-based compensation for all stock awards

The allocation of stock-based compensation for all stock awards is as follows (in thousands):

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

$

2,448

 

 

$

5,295

 

 

$

10,146

 

 

$

16,248

 

General and administrative

 

 

2,413

 

 

 

6,470

 

 

 

9,250

 

 

 

16,128

 

Total

 

$

4,861

 

 

$

11,765

 

 

$

19,396

 

 

$

32,376

 

Schedule of weighted-average assumptions used to determine the fair value of employee and nonemployee stock option grants

The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee and nonemployee stock option grants were as follows:

 

 

Nine Months Ended
September 30,

 

 

 

2025

 

 

2024

 

Risk-free interest rate

 

 

4.4

%

 

 

3.9

%

Expected volatility

 

 

90.4

%

 

 

87.1

%

Expected term (in years)

 

 

6.2

 

 

 

6.4

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Summary of changes in stockholders' equity

The following table summarizes the Company’s changes in stockholders’ equity accounts for the three and nine months ended September 30, 2025 (in thousands, except share data):

 

 

Convertible
Preferred Stock

 

 

Common
Stock

 

 

Additional
Paid-in

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

Total Stockholders'

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Gain (Loss)

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2024

 

2,755,086

 

 

$

3

 

 

 

113,928,279

 

 

$

114

 

 

$

1,716,335

 

 

$

268

 

 

$

(1,397,994

)

 

$

318,726

 

Issuance of common stock upon vesting of restricted stock units

 

 

 

 

 

 

 

675,631

 

 

 

1

 

 

 

(1

)

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

7,381

 

 

 

 

 

 

 

 

 

7,381

 

Unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(77

)

 

 

 

 

 

(77

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(37,621

)

 

 

(37,621

)

Balance at March 31, 2025

 

2,755,086

 

 

$

3

 

 

 

114,603,910

 

 

$

115

 

 

$

1,723,715

 

 

$

191

 

 

$

(1,435,615

)

 

$

288,409

 

Exercise of stock options, net of issuance costs

 

 

 

 

 

 

 

832

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

832

 

Issuance of common stock upon vesting of restricted stock units

 

 

 

 

 

 

 

50,325

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

50,325

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

7,154

 

 

 

 

 

 

 

 

 

7,154

 

Unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(129

)

 

 

 

 

 

(129

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(34,070

)

 

 

(34,070

)

Balance at June 30, 2025

 

2,755,086

 

 

$

3

 

 

 

114,655,067

 

 

$

115

 

 

$

1,730,869

 

 

$

62

 

 

$

(1,469,685

)

 

$

261,364

 

Issuance of common stock upon vesting of restricted stock units

 

 

 

 

 

 

 

681,630

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

681,630

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

4,861

 

 

 

 

 

 

 

 

 

4,861

 

Unrealized gain on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

91

 

 

 

 

 

 

91

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(32,250

)

 

 

(32,250

)

Balance at September 30, 2025

 

2,755,086

 

 

$

3

 

 

 

115,336,697

 

 

$

115

 

 

$

1,735,730

 

 

$

153

 

 

$

(1,501,935

)

 

$

234,066

 

 

The following table summarizes the Company’s changes in stockholders’ equity accounts for the three and nine months ended September 30, 2024 (in thousands, except share data):

 

 

Convertible
Preferred Stock

 

 

Common
Stock

 

 

Additional
Paid-in

 

 

Accumulated
Other
Comprehensive

 

 

Accumulated

 

 

Total Stockholders'

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Gain (Loss)

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2023

 

2,761,108

 

 

$

3

 

 

 

98,627,076

 

 

$

99

 

 

$

1,580,032

 

 

$

15

 

 

$

(1,211,732

)

 

$

368,417

 

Exercise of stock options, net of issuance costs

 

 

 

 

 

 

 

45,438

 

 

 

 

 

 

299

 

 

 

 

 

 

 

 

 

299

 

Issuance of common stock upon vesting of restricted stock units

 

 

 

 

 

 

 

580,974

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

10,981

 

 

 

 

 

 

 

 

 

10,981

 

Public offering of common stock, net of issuance costs

 

 

 

 

 

 

 

14,545,454

 

 

 

15

 

 

 

74,620

 

 

 

 

 

 

 

 

 

74,635

 

Private placement of pre-funded warrants, net of issuance costs

 

 

 

 

 

 

 

 

 

 

 

 

 

19,996

 

 

 

 

 

 

 

 

 

19,996

 

Unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(209

)

 

 

 

 

 

(209

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(48,004

)

 

 

(48,004

)

Balance at March 31, 2024

 

2,761,108

 

 

$

3

 

 

 

113,798,942

 

 

$

114

 

 

$

1,685,928

 

 

$

(194

)

 

$

(1,259,736

)

 

$

426,115

 

Exercise of stock options, net of issuance costs

 

 

 

 

 

 

 

 

 

 

 

 

 

(4

)

 

 

 

 

 

 

 

 

(4

)

Issuance of common stock upon vesting of restricted stock units

 

 

 

 

 

 

 

50,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

9,630

 

 

 

 

 

 

 

 

 

9,630

 

Public offering of common stock, net of issuance costs

 

 

 

 

 

 

 

 

 

 

 

 

 

(104

)

 

 

 

 

 

 

 

 

(104

)

Unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(228

)

 

 

 

 

 

(228

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(38,427

)

 

 

(38,427

)

Balance at June 30, 2024

 

2,761,108

 

 

$

3

 

 

 

113,849,557

 

 

$

114

 

 

$

1,695,450

 

 

$

(422

)

 

$

(1,298,163

)

 

$

396,982

 

Issuance of common stock upon vesting of restricted stock units

 

 

 

 

 

 

 

35,327

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

11,765

 

 

 

 

 

 

 

 

 

11,765

 

Unrealized gain on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,257

 

 

 

 

 

 

1,257

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(47,678

)

 

 

(47,678

)

Balance at September 30, 2024

 

2,761,108

 

 

$

3

 

 

 

113,884,884

 

 

$

114

 

 

$

1,707,215

 

 

$

835

 

 

$

(1,345,841

)

 

$

362,326